对抗抑郁药物的交替剂量可能导致严重的戒断效应:
James R O'Neill1, Anders Sørensen2, David Taylor3
1Faculty of Medicine and Health, University of Leeds, LS2 9JT, UK; South West Yorkshire Partnership NHS Foundation Trust, Wakefield WF1 3SP, UK.
Journal of affective disorders
|August 23, 2025
概括
在逐渐减少期间每隔一天服用抗抑郁药物会增加受体占用率的变化,可能导致戒断症状. 这种策略不推用于降低抗抑郁剂剂量.
科学领域:
- 药理学和临床药学
- 神经科学
- 药物代谢和药物动力学
背景情况:
- 临床医生经常建议每隔一天服用抗抑郁药,以逐渐降低每日平均剂量,通常作为液体配方的替代品.
- 有限的证据支持这种逐渐缩小的方法的有效性和安全性.
- 本研究研究了剂量间隔延长对常用抗抑郁药的受体占用率的影响.
研究的目的:
- 分析五种主要抗抑郁药物 (西塔洛普拉姆,埃斯蒂塔洛普拉姆,塞特拉林,杜洛西丁,米尔塔扎) 随着剂量间隔的改变而发生的受体占用变化.
- 确定是否延长剂量间隔会增加抗抑郁药物戒断症状的风险.
主要方法:
- 在5种抗抑郁药的药理学数据 (生物可用性,分布量,Tmax,半衰期) 的分析中.
- 用于模拟改变剂量频率对药物度的影响的药物动力学模型.
- 使用现有的成像数据和预定义的耐受性值,预测目标受体占用率.
主要成果:
- 延长剂量间隔显著增加了所有研究的抗抑郁药物的受体占用率变化,即使是标准剂量.
- 这种变化随着剂量下降而加剧,特别是在ED50 (有效剂量中位数) 附近.
- 增加剂量间隔以达到或低于最低治疗剂量可能会增加戒断症状的风险.
结论:
- 预计每隔一天服用抗抑郁药物会诱发西塔洛普拉姆,埃斯基塔洛普拉姆,塞特拉林,杜洛西丁和米尔塔萨的戒断效应.
- 这些发现表明这种逐渐减少的策略不应推.
- 需要进一步的临床研究和经验验证,以证实这些理论建议.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
344
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
344
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
568
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
568
01:20Desensitization and Tachyphylaxis
2.2K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.2K
01:25Antidepressant Drugs: Overview
750
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
750
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
296
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
296
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
241
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
241